Sheldon Sloan

Companies

• Aeglea BioTherapeuticsChief Medical Officer Oct 1, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ABAeglea BioTherapeutics SYRE0 shares²Jul 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 1, 2026Sold 1,834 shares at $88.34 of Aeglea BioTherapeutics²
• Jul 1, 2026Sold 6,500 shares at $87.52 of Aeglea BioTherapeutics²
• Jul 1, 2026Exercised options 8,334 shares at $27.46 of Aeglea BioTherapeutics²
• Jun 3, 2026Sold 8,333 shares at $75.00 of Aeglea BioTherapeutics³
• Jun 3, 2026Exercised options 8,333 shares at $27.46 of Aeglea BioTherapeutics³
• May 1, 2026Sold 400 shares at $75.37 of Aeglea BioTherapeutics⁴
• May 1, 2026Sold 5,059 shares at $74.60 of Aeglea BioTherapeutics⁴
• May 1, 2026Sold 10,358 shares at $73.74 of Aeglea BioTherapeutics⁴
• May 1, 2026Sold 12,777 shares at $72.94 of Aeglea BioTherapeutics⁴
• May 1, 2026Sold 8,777 shares at $71.56 of Aeglea BioTherapeutics⁴
• May 1, 2026Sold 19,656 shares at $70.61 of Aeglea BioTherapeutics⁴
• May 1, 2026Sold 21,306 shares at $69.53 of Aeglea BioTherapeutics⁴
• May 1, 2026Exercised options 78,333 shares at $27.46 of Aeglea BioTherapeutics⁴
• Apr 1, 2026Sold 7,958 shares at $50.00 of Aeglea BioTherapeutics⁵
• Apr 1, 2026Exercised options 7,958 shares at $21.66 of Aeglea BioTherapeutics⁵